Securities and Exchange Commission filings indicate that Oxford Finance LLC acquired 1.62 million common shares, representing 16.5% ownership in the clinical-stage company. Oxford Finance, the ...
KALA BIO Inc. (NASDAQ: KALA) jumped 37.87% to $0.88 in after-hours trading on Tuesday. Check out the current price of KALA stock here. According to Benzinga Pro data, the stock closed the regular ...
ARLINGTON, Mass. (AP) — ARLINGTON, Mass. (AP) — KALA BIO, Inc. (KALA) on Wednesday reported a loss of $7.6 million in its third quarter. On a per-share basis, the Arlington, Massachusetts-based ...
Even as office wear becomes more casual, plenty of people are donning jackets and trousers — sometimes even together. Our critic offers advice for suiting up. By Vanessa Friedman Is it my imagination, ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Arlington biotech Kala Bio has ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement from Kala Pharmaceuticals ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Arlington biotech has been ...
Kala Bio said it laid off most of its employees after receiving notice that its lender, Oxford Finance, intends to foreclose on all of its remaining assets. The move follows the biotech company's ...
Shares of KALA BIO KALA have nosedived 88.3% in a month after the company announced the failure of a mid-stage study evaluating its only clinical pipeline candidate, KPI-012, for the treatment of ...
Kala Bio, Inc. (NASDAQ:KALA), a biotech company with a market capitalization of $10.74 million and showing significant stock volatility, announced it received a written notice of default from Oxford ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results